Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2023

Open Access 01-12-2023 | Research

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy

Authors: Wanyu Jia, Wenjie Dou, Qin Wang, Huiqin Zeng, Peipei Shi, Jing Liu, Zhen Liu, Jin Zhang, Jian-Jiang Zhang

Published in: Italian Journal of Pediatrics | Issue 1/2023

Login to get access

Abstract

Background

IgA nephropathy (IgAN) is a common primary renal disease in childhood.

Methods

Twenty blood samples and renal tissue from patients with IgAN, 20 blood samples from healthy children and 10 normal renal tissue were collected. Serum Gd-IgA1 and renal Gd-IgA1, CD31, α-SMA and vimentin were measured.

Results

The serum Gd-IgA1 concentration in the IgAN group was significantly higher. Gd-IgA1 was not expressed in normal kidneys, which was positive in the IgAN group. Gd-IgA1 levels in serum and renal tissue were not related. The expression of CD31 decreased significantly in IgAN group, while the expression of α-SMA and vimentin increased significantly. There was no significant correlation between the renal concentration of Gd-IgA1 and CD31, α-SMA and vimentin.

Conclusion

The increased Gd-IgA1 in the serum and kidney may promote the pathogenesis of IgAN. The serum Gd-IgA1 cannot predict the extent of its deposition in the kidney. Endothelial mesenchymal transition (EndMT) may be involved in the pathogenesis of renal fibrosis in IgAN.
Literature
1.
go back to reference Kidney Disease. Improving global outcomes glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276. Kidney Disease. Improving global outcomes glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276.
2.
go back to reference Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the spectrum of kidney Diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10–9.CrossRefPubMed Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the spectrum of kidney Diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10–9.CrossRefPubMed
3.
go back to reference Ohyama Y, Renfrow MB, Novak J, Takahashi K. Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know. J Clin Med. 2021;10(16). Ohyama Y, Renfrow MB, Novak J, Takahashi K. Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know. J Clin Med. 2021;10(16).
4.
go back to reference Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119(6):1668–77.PubMedPubMedCentral Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119(6):1668–77.PubMedPubMedCentral
5.
go back to reference Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, et al. Galactose-deficient IgA1 as a candidate urinary polypeptide marker of IgA Nephropathy? Dis Markers. 2016;2016:7806438.CrossRefPubMedPubMedCentral Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, et al. Galactose-deficient IgA1 as a candidate urinary polypeptide marker of IgA Nephropathy? Dis Markers. 2016;2016:7806438.CrossRefPubMedPubMedCentral
6.
go back to reference Knoppova B, Reily C, King RG, Julian BA, Novak J, Green TJ. Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment. J Clin Med. 2021;10(19). Knoppova B, Reily C, King RG, Julian BA, Novak J, Green TJ. Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment. J Clin Med. 2021;10(19).
7.
go back to reference Suzuki H, Novak J. IgA glycosylation and immune complex formation in IgAN. Semin Immunopathol. 2021;43(5):669–78.CrossRefPubMed Suzuki H, Novak J. IgA glycosylation and immune complex formation in IgAN. Semin Immunopathol. 2021;43(5):669–78.CrossRefPubMed
8.
go back to reference Liu L, Sun Q, Davis F, Mao J, Zhao H, Ma D. Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies. Burns Trauma. 2022;10:tkac011.CrossRefPubMedPubMedCentral Liu L, Sun Q, Davis F, Mao J, Zhao H, Ma D. Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies. Burns Trauma. 2022;10:tkac011.CrossRefPubMedPubMedCentral
9.
go back to reference Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ. 2017;60:345–72.CrossRefPubMed Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ. 2017;60:345–72.CrossRefPubMed
10.
go back to reference Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration. Int J Mol Sci. 2020;21(12). Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration. Int J Mol Sci. 2020;21(12).
11.
go back to reference Hong L, Du X, Li W, Mao Y, Sun L, Li X. EndMT: a promising and controversial field. Eur J Cell Biol. 2018;97(7):493–500.CrossRefPubMed Hong L, Du X, Li W, Mao Y, Sun L, Li X. EndMT: a promising and controversial field. Eur J Cell Biol. 2018;97(7):493–500.CrossRefPubMed
12.
go back to reference Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in physiology and in the Pathogenesis of Human Diseases. Physiol Rev. 2019;99(2):1281–324.CrossRefPubMedPubMedCentral Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in physiology and in the Pathogenesis of Human Diseases. Physiol Rev. 2019;99(2):1281–324.CrossRefPubMedPubMedCentral
13.
go back to reference Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008;19(12):2282–7.CrossRefPubMedPubMedCentral Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008;19(12):2282–7.CrossRefPubMedPubMedCentral
14.
go back to reference Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol. 2009;175(4):1380–8.CrossRefPubMedPubMedCentral Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol. 2009;175(4):1380–8.CrossRefPubMedPubMedCentral
15.
go back to reference von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110(12):1628–45.CrossRef von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110(12):1628–45.CrossRef
16.
go back to reference Nephrology section CPS, Chinese Medical Association. Evidence-based guidelines for diagnosis and treatment of primary IgA nephropathy (2016). 中华儿科杂志. 2017;55(9):643–6. Nephrology section CPS, Chinese Medical Association. Evidence-based guidelines for diagnosis and treatment of primary IgA nephropathy (2016). 中华儿科杂志. 2017;55(9):643–6.
17.
go back to reference Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30(8):1315–21.CrossRefPubMedPubMedCentral Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30(8):1315–21.CrossRefPubMedPubMedCentral
18.
go back to reference Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Maldyk J, Dziedzic-Jankowska K, Leszczynska B, et al. Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schonlein nephritis. Cent Eur J Immunol. 2018;43(2):162–7.CrossRefPubMedPubMedCentral Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Maldyk J, Dziedzic-Jankowska K, Leszczynska B, et al. Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schonlein nephritis. Cent Eur J Immunol. 2018;43(2):162–7.CrossRefPubMedPubMedCentral
19.
go back to reference Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700–5.CrossRefPubMed Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700–5.CrossRefPubMed
20.
go back to reference Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, et al. Plasma galactose-deficient IgA1 and C3 and CKD progression in IgA Nephropathy. Clin J Am Soc Nephrol. 2019;14(10):1458–65.CrossRefPubMedPubMedCentral Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, et al. Plasma galactose-deficient IgA1 and C3 and CKD progression in IgA Nephropathy. Clin J Am Soc Nephrol. 2019;14(10):1458–65.CrossRefPubMedPubMedCentral
21.
go back to reference Ma Z, Zhu L, Liu Y, Wang Z, Yang Y, Chen L, et al. Lovastatin alleviates endothelial-to-mesenchymal transition in Glomeruli via suppression of oxidative stress and TGF-beta1 signaling. Front Pharmacol. 2017;8:473.CrossRefPubMedPubMedCentral Ma Z, Zhu L, Liu Y, Wang Z, Yang Y, Chen L, et al. Lovastatin alleviates endothelial-to-mesenchymal transition in Glomeruli via suppression of oxidative stress and TGF-beta1 signaling. Front Pharmacol. 2017;8:473.CrossRefPubMedPubMedCentral
22.
go back to reference Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, et al. ROCK1 induces endothelial-to-mesenchymal transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep. 2016;6:20304.CrossRefPubMedPubMedCentral Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, et al. ROCK1 induces endothelial-to-mesenchymal transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep. 2016;6:20304.CrossRefPubMedPubMedCentral
23.
go back to reference Liu F, Zhang S, Xu R, Gao S, Yin J. Melatonin attenuates endothelial-to-mesenchymal transition of glomerular endothelial cells via regulating miR-497/ROCK in Diabetic Nephropathy. Kidney Blood Press Res. 2018;43(5):1425–36.CrossRefPubMed Liu F, Zhang S, Xu R, Gao S, Yin J. Melatonin attenuates endothelial-to-mesenchymal transition of glomerular endothelial cells via regulating miR-497/ROCK in Diabetic Nephropathy. Kidney Blood Press Res. 2018;43(5):1425–36.CrossRefPubMed
24.
go back to reference Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, et al. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation. Arch Med Res. 2010;41(4):255–60.CrossRefPubMed Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, et al. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation. Arch Med Res. 2010;41(4):255–60.CrossRefPubMed
25.
go back to reference Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H. Synergistic effect of mesangial cell-induced CXCL1 and TGF-beta1 in promoting podocyte loss in IgA nephropathy. PLoS ONE. 2013;8(8):e73425.CrossRefPubMedPubMedCentral Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H. Synergistic effect of mesangial cell-induced CXCL1 and TGF-beta1 in promoting podocyte loss in IgA nephropathy. PLoS ONE. 2013;8(8):e73425.CrossRefPubMedPubMedCentral
26.
go back to reference Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P. TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci. 2017;18(10). Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P. TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci. 2017;18(10).
Metadata
Title
Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
Authors
Wanyu Jia
Wenjie Dou
Qin Wang
Huiqin Zeng
Peipei Shi
Jing Liu
Zhen Liu
Jin Zhang
Jian-Jiang Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2023
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-023-01468-x

Other articles of this Issue 1/2023

Italian Journal of Pediatrics 1/2023 Go to the issue